Search

Your search keyword '"Gompels, M."' showing total 341 results

Search Constraints

Start Over You searched for: Author "Gompels, M." Remove constraint Author: "Gompels, M."
341 results on '"Gompels, M."'

Search Results

1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.

3. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

6. A highly virulent variant of HIV-1 circulating in the Netherlands

7. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response:a sub-study of the NEAT001/ANRS143 randomized trial

9. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

13. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

14. Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK

19. Estimated glomerular filtration rate slopes on tenofovir alafenamide

22. Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz

23. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

24. Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age >= 50 Years: Final 96-Week Results of the NEAT022 Study

25. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

26. Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

29. C1 inhibitor deficiency: consensus document

39. T-cell receptor variable gene products and early HIV-1 infection

40. Disseminated Pneumocystis carinii infection in AIDS

41. Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data

46. Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

47. Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.

Catalog

Books, media, physical & digital resources